Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026

Net revenues of $171.2 million for the three months ended March 31, 2026GAAP net income of $6.4 million, or $0.14 per share, for the first quarterAdjusted non-GAAP net income of $19.5 million, or $0.42 per share, for the first quarterCompany to hold …